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The diagnosis of Q fever endocarditis cannot be made by bacterial cultures and necessitates serological
identification of specific antibodies to Coxiella burnetii which stimulates mainly the production of anti-phase
II antibodies during the acute disease, but primarily anti-phase I antibodies in endocarditis. Indirect micro-
immunofluorescence allows rapid detection of specific IgA, IgG andlgM. The results of serological analyses of
191 acute cases of Q fever were compared with those of 8 cases o/Coxiella burnetii endocarditis. All sera were
evaluated by complement fixation and microimmunqfluorescence tests. The highest titre differences between
primary Q fever and Q fever endocarditis were observed with anti-phase I IgA and IgG antibodies measured by
microimmunofluorescence followed by anti-phase I antibodies measured by complement fixation tests. Anti-
phase I IgG andlgM titres were consistently higher than anti-phase II titres in endocarditis. The reverse is true
in acute Q fever. In addition, anti-phase I IgA appeared to be diagnostic for Coxiella burnetii endocarditis.
Accordingly we recommend the testing of these specific IgA, IgG, andlgM by microimmunofluorescence in
cases of culture-negative endocarditis. These tests could also prove useful for following the development of
Coxiella burnetii endocarditis in patients under treatment.
Introduction
Primary or acute Q fever is an influenza-like
infection, frequently accompanied by pneumonia.
It normally follows a benign course, although
progression to a chronic stage, Coxiella burnetii
endocarditis, may occur and presents a dangerous
complication'11. Although only about 200 cases have
been reported so far, Q fever endocarditis appears
to occur more frequently than assumed. Most cases
have been discovered in the United Kingdom and
Australia'2"4'.
The frequency of endocarditis after primary Q
fever is estimated to be in the order of 1 to 2%, but so
far no work has been done to confirm this. The
latency period between the acute or primary phase,
which has often gone undiagnosed, and endocarditis
is still unknown, with estimates ranging from 2 to 20
years. Although more often diagnosed in middle-
aged men, Q fever endocarditis can also affect
women and children'5!. Clinically, it presents itself
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as a culture-negative endocarditis, with patients
suffering from fever, tachycardia, heart murmur,
hepatomegaly and splenomegaly. Often there is a
history of pre-existing mitral or aortic valvular
lesion'67'. Nonspecific laboratory examinations
often reveal a leucocytosis with anaemia and
thrombopenia, hypergammaglobulinaemia and
pathologic liver tests'8!, with a mortality rate of up
to 50%, even with medical and surgical treatment, it
is imperative to diagnose these cases at the earliest
possible time to shorten delay of effective antibiotic
therapy. Isolation of C. burnetii from routine blood
cultures is not possible, and only serology allows a
clinical diagnosis. Inoculation of guinea pigs with
valvular tissues taken during surgery frequently
allows a definite confirmation of the diagnosis.
Unique to C. burnetii is its antigenic phase vari-
ation. The virulent phase I is isolated from natural or
laboratory infections of animals and man, whereas
the avirulent phase II occurs during serial passage
of C. burnetii in immunologically incompetent
hosts, such as embryonated hen eggs or cell tissue
culture systems. Phase I to II variation seems to
correlate with smooth and rough lipopolysaccharide
changes'9). Specific high levels of anti-phase I anti-
bodies are normally found in chronic Q fever
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(endocarditis), whereas specific anti-phase II
antibodies predominate during primary Q fever.
The serological test most commonly used up to
the present time has been the complement fixation
(CF) test, with anti-phase I antibody titres greater
than 1:200 being considered diagnostic of C.
burnetii endocarditis. However, cases have been
discovered with titres below this level''!. Among the
more sensitive serological tests developed during the
last few years, is the microimmunofluorescence test
(IFA), which allows the rapid and easy detection of
specific IgA, IgG and IgM antibodies to phase I and
phase II C. burnetiim.
This paper deals with a comparative serological
analysis of the CF and IFA tests in 8 cases of Q fever
endocarditis and in 191 cases of acute Q fever!"'.
Materials and methods
The sera of the 8 patients suffering from culture-
negative endocarditis were obtained from the
Departments of Internal Medicine of the University
Hospitals at Zurich and Berne and from the
Pediatric Service of the University Hospital at
Geneva. The diagnosis of Q fever endocarditis for
each of these cases was established between 1980 and
1984 according to the classically known criterion
of an anti-phase I antibody titre greater than 1:200
in CF. The IFA analyses (IgA, IgG, IgM, to C.
burnetii phases I and II) were performed from
frozen serum specimens in late 1984. Only results of
the first sample from each patient, i.e. before any
antibiotic therapy, are reported here.
A short description of the patients condition at
the time of the diagnosis is presented. Patient 1 was
admitted for surgical correction of a ventricular
septal defect. Follow-up clinical investigation
revealed an endocarditis with fever, hepatospleno-
megaly, and negative blood cultures. A liver biopsy
showed a granulomatous hepatitis. Guinea pigs
inoculated with the patient's blood developed anti-
bodies to C. burnetii. The patient's serum showed
high CF anti-phase I antibody titre. Patients 2 and 3
were admitted for a fever of unknown origin, and
with aortic regurgitation. Investigations revealed
an endocarditis, negative blood cultures and a high
CF anti-phase I antibody titre. Patient 4 was admit-
ted for surgical correction of a tetralogy of Fallot.
Clinical investigation revealed an endocarditis with
fever, hepatosplenomegaly, negative blood cultures
and a high CF anti-phase I antibody titre. Patient
5 underwent an aortic valve replacement for stenosis
in November 1979. In June 1982, he was admitted
for fever of unknown origin. The follow-up clinical
investigations revealed endocarditis, negative blood
cultures and a high CF anti-phase I antibody titre.
He was treated with cotrimoxazole and rifampicin.
In January 1983, he underwent a second aortic
valve replacement for regurgitation. C. burnetii
was isolated from heart valve tissue. Patient 6 was
admitted for a fever of unknown origin. Follow-up
clinical investigations revealed an endocarditis,
negative blood cultures and a high CF anti-phase I
antibody titre. Patient 7 presented a serologically
confirmed acute Q fever in 1973. He underwent a
first aortic valve replacement for regurgitation in
1977 and a second in April 1981. He was admitted in
November 1981 for a fever of unknown origin with
heart failure. Follow-up clinical investigations
revealed an endocarditis, negative blood cultures
and a high CF anti-phase I antibody titre. Patient 8
underwent in January 1985 an aortic, mitral and
tricuspid valve replacement for rheumatic heart
disease. Clinical investigations revealed an endo-
carditis with fever, negative blood cultures and a
high CF anti-phase I antibody titre.
The 191 sera from patients with acute Q fever
were sent to us by physicians in Le Chable during an
epidemic in the Val de Bagnes (Valais) in the
autumn of 1983. All 191 sera were examined by CF
and IFA (IgA, IgG, IgM) tests for anti-phase I and
II antibodies to C. burnetipw. Sera of 12 patients
suffering from streptococcal endocarditis were also
examined for these antibodies.
Complement fixation test (CF)
The micro-method was performed as described
by the Centers for Disease Control (CDC, Atlanta,
GA, U.S.A)i'4i except that the starting serum
dilution was 1:10 and the sensitized erythrocyte
concentration was 2-5%. The antigen C. burnetii
phase I was of strain Herzberg (Veterinaria AG,
Zurich, Switzerland) and the antigen C. burnetii
phase II was of strain Nine Mile (Virion AG,
Ruschlikon, Switzerland). Serum, antigen, comple-
ment (Virion AG) and haemoly tic system (Boehring,
Marburg, Germany), were prepared in veronal
buffer (Oxoid BR 16). The end point was defined as
the highest dilution with ^ 75% fixation. Results
are expressed as reciprocal titres (for example 200
for the 1:200 dilution).
Indirect microimmunofluorescence test (IFA)
The IFA tests were performed according to the
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Table 1 Reciprocal C. bumetii titres in patients with Q-fever endocarditis obtained with the complement fixation test and the
microimmunofluorescence test using antigens of phase I and II
Patient
1
2
3
4
5
6
7
g
Average
Complement fixation
I
640
320
1280
640
640
640
640
640
679
II
160
1280
1280
640
20
1280
640
640
742
IgG
I
40960
20480
40960
20480
20480
40960
20480
20480
28 160
Microimmunofluorescence
II
640
20480
20480
2560
2560
20480
5120
5120
9680
IgM
I
320
640
640
80
640
640
160
160
410
II
20
640
320
80
40
320
80
20
188
IgA
I
160
1280
2560
160
160
320
2560
320
940
II
20
40
320
20
1280
20
160
1280
390
Rheumatoid
factor
+
+
+
+
+
+
+
+
+
method described by Philip et al.liS]. The C. bumetii
phase I antigen (Nine Mile strain) had been passed
307 times in guinea pigs, cloned from primary
chicken embryo cell culture plaques and passed
twice in chicken embryos. The C. bumetii phase II
antigen (strain Nine Mile) had been passed 90 times
in chicken embryos, cloned from primary chicken
embryo cell culture plaques and passed three times
in chicken embryos. Antigens of C. bumetii phase I
and II were applied side by side to microscope slides
with a pen over a premarked 18-dot template. We
used FITC (fluorescein isothiocyanate) goat anti-
human IgM and IgG conjugates (Biomerieux,
France), and rabbit anti-human IgA conjugate
(Dakopatts, Denmark). IgM reactive sera were
tested for rheumatoid factor with the rheumatoid
factor tube test 'Roche' (Roche Diagnostica, Basel,
Switzerland).
Results
Table I shows individual and average titres for
sera taken at the moment of diagnosis from the 8
cases of C. bumetii endocarditis. Phase I CF titres
were consistently above 200, with an average titre of
679. Anti-phase I IgG titres by IFA were consist-
ently higher with an average titre of 28 160.
Figure 1 illustrates the quantitative relationship
between the average titres for the 191 cases of acute Q
fever and for the 8 cases of C. bumetii endocarditis.
The highest titre differences between primary Q
fever and Q fever endocarditis were observed with
anti-phase I IgA and IgG antibodies measured by
IFA, followed by anti-phase I antibodies measured
byCF.
Table 2 compares the range of titres obtained
with the two tests for the 8 cases of endocarditis and
the 191 cases of acute Q fever. Antibodies to phase I
in CF as well as anti-phase I IgA and IgG in IFA
tests were never present at significant levels in
primary Q fever but were very high in endocarditis.
An overlap of elevated titres was regularly observed
in phase II titres. Phase I IFA titres were always
equal or superior to phase II titres except for IgA in
cases 5 and 8. Rheumatoid factor was positive in all
8 cases.
In the 12 sera from patients suffering from strep-
tococcal endocarditis, no anti-phase I or II IgA or
IgM against C. bumetii were detected. In the sera
from 3 patients only residual anti-phase I and II
IgG were found. No rheumatoid factor was
detected.
Discussion
Antibody titres to C. bumetii phase I, measured
by CF, were always greater than 200 in all eight
cases of endocarditis. In contrast, none of the 191
cases of primary Q fever presented a titre greater
than 20. This confirms the validity of the diagnostic
criterion of phase I antibody titres in the diagnosis
of Q fever endocarditis. However, titres of less than
200, do not exclude this diagnosis!'). Antibody titres
to C. bumetii phase II by CF cannot distinguish
endocarditis from primary Q fever because they are
often at the same level.
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Figure 1 Average reciprocal C. burnetii titres in patients with primary Q fever (191 cases)
and Q fever endocarditis (8 cases) obtained with the complement fixation test (CF) and
microimmunofiuorescence test (IgG, IgM, IgA) using antigens of phase I and II.
Table 2 Range of reciprocal C. burnetii titres in patients
with Q fever endocarditis and primary Q-fever obtained with
the complement fixation test (CF) and the microimmuno-
fiuorescence test (IFA) using antigens of phase I and II
Serologic test Endocarditis(N=8)
Primary Q fever
(#=191)
•• CFI
CFII
IFA IgG I
• IgG II
IFA IgM I
• IgM II
IFA IgA I
IgA II
Rheumatoid factor
320-1280
20-1280
20480-40960
640-20480
80-640
<20-640
160-2560
<20-1280
40-320
<10-20
40-1280
<2<M0
320-10 240
<20-640
80-10 240
<20
<20-320
<20
With IFA, anti-phase I IgG antibodies can be
detected at very high dilutions in endocarditis only;
the average titre for the 8 cases was approximately
28 000 whereas it was 17 in the 191 cases of acute Q
fever. Anti-phase I IgG appears to be the most
sensitive discriminator, since none of the 8 cases of
endocarditis had a level below 20 480, whereas none
of the 191 cases of primary Q fever had a level above
40. Because anti-phase II IgG are raised in both the
acute and the chronic disease state, they are of no
differential diagnostic value. Moreover, in each
individual case, anti-phase I IgG titre was always
equal or higher than anti-phase II IgG titre in endo-
carditis, and greatly lower in primary Q fever. Our
results correlate well with those reported by Peacock
et a/."0' for their 5 cases of Q fever endocarditis.
With IFA, anti-phase I IgM are usually present at
slightly higher levels than those of anti-phase II IgM
in cases of endocarditis; the reverse is true in acute
cases. However, due to the presence of rheumatoid
factors in cases of C. burnetii endocarditis, the
clinical significance of these IgM titres is uncertain.
On the other hand, the rheumatoid factor being
absent in acute Q fever, IgM is diagnostic in that
easel'2!.
Elevated anti-phase I IgA titres were found in
all 8 patients and appear to be diagnostic for C.
burnetii endocarditis. In contrast, such titres were
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undetectable in the 191 cases of acute Q fever. On
the other hand, anti-phase II IgA antibodies in
variable titres were found in both clinical conditions
as reported by others'16'. Consequently, only anti-
phase I IgA is a useful indicator for suspected cases
of C. burnetii endocarditis.
No significant levels of IgA, IgG and IgM anti-C
burnetii phase I or II were found in the sera of the 12
persons with streptococcal endocarditis.
In addition to the CF test, the clinician can now
use the IFA test, a sensitive, rapid and simple
method, to establish the diagnosis of C. burnetii
endocarditis. In accordance with Peacock et a/.'10'
we found that the most sensitive parameters for the
diagnosis of C. burrtetii endocarditis are anti-phase
I IgA and IgG. Another possible advantage of these
indicators identified by IFA would be their earlier
appearance in sera from patients developing a C.
burnetii endocarditis. Regular checks of all the cases
of acute Q fever we diagnosed in 1983 will possibly
confirm this. The level of these indicators during
control checks of cases of C. burnetii endocarditis
under treatment could also prove useful.
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